A Thia-Analogous Indirubin N-Glycoside Disrupts Mitochondrial Function and Causes the Death of Human Melanoma and Cutaneous Squamous Cell Carcinoma Cells
Author:
Wendt Franziska1, Wittig Felix1, Rupprecht Anne1, Ramer Robert1, Langer Peter2, Emmert Steffen3ORCID, Frank Marcus45ORCID, Hinz Burkhard1ORCID
Affiliation:
1. Institute of Pharmacology and Toxicology, Rostock University Medical Centre, 18057 Rostock, Germany 2. Institute of Organic Chemistry, University of Rostock, 18059 Rostock, Germany 3. Clinic and Policlinic for Dermatology, Rostock University Medical Centre, 18057 Rostock, Germany 4. Electron Microscopy Centre, Rostock University Medical Centre, 18057 Rostock, Germany 5. Department Life, Light and Matter, University of Rostock, 18059 Rostock, Germany
Abstract
Skin cancer is the most common malignant disease worldwide and, therefore, also poses a challenge from a pharmacotherapeutic perspective. Derivatives of indirubin are an interesting option in this context. In the present study, the effects of 3-[3′-oxo-benzo[b]thiophen-2′-(Z)-ylidene]-1-(β-d-glucopyranosyl)-oxindole (KD87), a thia-analogous indirubin N-glycoside, on the viability and mitochondrial properties of melanoma (A375) and squamous cell carcinoma cells (A431) of the skin were investigated. In both cell lines, KD87 caused decreased viability, the activation of caspases-3 and -7, and the inhibition of colony formation. At the mitochondrial level, a concentration-dependent decrease in both the basal and ATP-linked oxygen consumption rate and in the reserve capacity of oxidative respiration were registered in the presence of KD87. These changes were accompanied by morphological alterations in the mitochondria, a release of mitochondrial cytochrome c into the cytosol and significant reductions in succinate dehydrogenase complex subunit B (SDHB, subunit of complex II) in A375 and A431 cells and NADH:ubiquinone oxidoreductase subunit B8 (NDUFB8, subunit of complex I) in A375 cells. The effect of KD87 was accompanied by a significant upregulation of the enzyme heme oxygenase-1, whose inhibition led to a partial but significant reduction in the metabolic-activity-reducing effect of KD87. In summary, our data show a mitochondria-targeting effect of KD87 as part of the cytotoxic effect of this compound on skin cancer cells, which should be considered in future studies with this class of compounds.
Funder
ONKOTHER-H Ministry of Education, Science and Culture of Mecklenburg-Vorpommern, Germany
Reference77 articles.
1. Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities;Eddy;Front. Oncol.,2020 2. Schäfer, M., Semmler, M.L., Bernhardt, T., Fischer, T., Kakkassery, V., Ramer, R., Hein, M., Bekeschus, S., Langer, P., and Hinz, B. (2021). Small Molecules in the Treatment of Squamous Cell Carcinomas: Focus on Indirubins. Cancers, 13. 3. Cancer Statistics, 2021;Siegel;CA Cancer J. Clin.,2021 4. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021 5. Ramer, R., Wendt, F., Wittig, F., Schäfer, M., Boeckmann, L., Emmert, S., and Hinz, B. (2022). Impact of Cannabinoid Compounds on Skin Cancer. Cancers, 14.
|
|